Neutral Cholesterol Ester Hydrolase 1 (NCEH1) (C-Term) Peptide
Quick Overview for Neutral Cholesterol Ester Hydrolase 1 (NCEH1) (C-Term) Peptide (ABIN8106440)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- NCEH1 Peptide - C-terminal region
-
Sequence
- GIMYAKRLES AGVEVTLDHF EDGFHGCMIF TSWPTNFSVG IRTRNSYIKW
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-NCEH1 Antibody (ARP49570_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- NCEH1 (Neutral Cholesterol Ester Hydrolase 1 (NCEH1))
-
Background
-
Background Information: NCEH1 hydrolyzes 2-acetyl monoalkylglycerol ether, the penultimate precursor of the pathway for de novo synthesis of platelet-activating factor. It may be responsible for cholesterol ester hydrolysis in macrophages, thereby contributing to the development of atherosclerosis. NCEH1 also involved in organ detoxification by hydrolyzing exogenous organophosphorus compounds. It may contribute to cancer pathogenesis by promoting tumor cell migration.
Alternative Symbols: NCEH1,AADACL1, KIAA1363,
-
Molecular Weight
- 30kDa
-
Gene ID
- 57552
-
UniProt
- Q6PIU2
Target
-
